Cooper Companies, Inc. (COO)

Over the past six months, The Cooper Companies' stock price declined by 9.60%. Key events included the release of Q2, Q3, and Q4 2025 results, an expanded share repurchase program, the announcement of a new Chair of the Board and a strategic review, the appointment of Walter M. Rosebrough, Jr. to the Board of Directors, and participation in healthcare conferences.

Demand for The Cooper Companies' products and services exhibits some seasonality, with quarterly results generally expected to follow seasonal trends, with a lighter start to the fiscal year. Historical seasonal chart analysis suggests a "Buy Date" of December 13 and a "Sell Date" of March 10 has resulted in outperformance compared to the S&P 500 Total Return Index over the past 20 years. Demand for MyDay contact lenses has at times exceeded manufacturing capacity.

The Cooper Companies, Inc. operates in the Health Technology sector, focusing on Medical Specialties and Medical Equipment. CooperVision develops, manufactures, and markets contact lenses for various vision challenges, with key brands including MyDay and Biofinity. CooperSurgical focuses on fertility and women's healthcare, offering products and services such as ART devices, surgical instruments, and the Paragard IUD.

The Cooper Companies has a significant global presence, operating in over 130 countries across Europe, Asia, Africa, and the Americas, impacting more than fifty million lives annually.

In the past year, The Cooper Companies has maintained a positive brand reputation through innovation and employee recognition, including being recognized as a "Best Workplace for Innovators." The company's commitment to research and development and strategic acquisitions have bolstered its offerings in eyecare, women's health, and fertility. No specific negative events impacting its brand reputation were prominently reported.

The Cooper Companies, Inc. is primarily owned by institutional shareholders, who hold between 87.35% and 104.06% of the stock. Major institutional owners include Vanguard Group Inc., BlackRock, Inc., and Capital World Investors. Insider ownership ranges from 0.54% to 1.23%.